Rheumatoid arthritis and the concept of autoimmune disease
Journal Title: International Journal of Clinical Rheumatology - Year 2019, Vol 14, Issue 2
Abstract
We critically review the concept of autoimmunity in Rheumatoid Arthritis (RA). To classify a disease as autoimmune, it is necessary to demonstrate that the immune response to a self-antigen causes the observed pathology. In RA, neither autoantigens nor autoreactive T-cell clones were found. Molecular mimicry exists in some cases, e.g. after Proteus mirabilis infection. In some patients, cross-reactivity between microbial DnaJ and human HSP40 can occur. However, none of the autoantibodies described in RA, with perhaps exception of Anti-Citrullinated Peptides Antibodies (ACPAs), are responsible for the onset of disease and tissue damage. ACPAs appeared early in the disease process and could activate macrophages. In turn, this leads to the release of pro-inflammatory cytokines that stimulate synovial fibroblasts. In this disease, neither autoantibodies, nor leucocytes destroy bone and cartilage. This is caused by aggressive epigenetically modified synovial fibroblasts. Current treatments did not directly target those cells. The term “autoimmune disease” for RA should be used with caution until the link between immune phenomena and joint damage has been elucidated. However, we have to be open and to accept that RA is a heterogeneous disease. This is reflected by the large variability of responses to immunosuppressive drugs or biologicals.
Authors and Affiliations
Stephan Neidhart, Michel Neidhart
Effect of colchicine treatment on primary knee osteoarthritic patients
Background and Aim: It was hypothesized that cartilage degradation in osteoarthritis (OA) facilitates monosodium urate crystals nucleation which by its turn contribute to progression of OA. The aim of the current study i...
Association of sarcoidosis and psoriasis: a difficult diagnosis
Sarcoidosis is a chronic multisystem disorder characterized by the formation of non caseating epithelioid cell granulomas affecting multiple organ systems. The role of the type 1 helper T (TH1) cells and type 17 helper T...
Targeted gene therapy in the management of osteoarthritis: back to the future with great expectations
Osteoarthritis (OA) is a degenerative joint disease of the articular cartilage with subchondral bone remodeling and secondary inflammation [1]. OA is the most common joint disease worldwide, a chief cause of chronic disa...
Long term follow up of an early oligoarthritis cohort shows that early aggressive intervention leads to drug free remission after 10 years: results from the LOTO study
Objective: To report the long-term outcome in the long-term follow up of the Leeds Early Oligoarthritis Cohort. Methods: Cross-sectional follow up of patients who participated in two previous interventional studies. Subj...
A case series of malignancies: mimics of Rheumatological disorders
Background: Malignancy and Autoimmunity interplay is full of complexities. We here, describe few cases of malignancies presented as mimics of autoimmune disorders. A case of acute myeloid leukaemia had leukocytoclastic v...